Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease

Author： D'Onofrio Grazia   Panza Francesco   Frisardi Vincenza   Solfrizzi Vincenzo   Imbimbo Bruno P   Paroni Giulia   Cascavilla Leandro   Seripa Davide   Pilotto Alberto  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.7, Iss.1, 2012-01, pp. : 19-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

&ggr;-Secretase Inhibitors and Modulators for the Treatment of Alzheimer's Disease: Disappointments and Hopes

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 12, 2011-06 ,pp. : 1555-1570

Bentham Science Publishers

Access to resources Recommend Favorite

Disease-Modifying Approach to the Treatment of Alzheimer's Disease: From α-Secretase Activators to γ-Secretase Inhibitors and Modulators

By Panza Francesco  

Drugs & Aging, Vol. 26, Iss. 7, 2009-07 ,pp. : 537-555

Adis International

Access to resources Recommend Favorite

γ-Secretase Inhibitors for Alzheimer's Disease: Balancing Efficacy and Toxicity

By Barten Donna M.   Meredith Jere E.   Zaczek Robert   Houston John G.   Albright Charles F.  

Drugs in R&D, Vol. 7, Iss. 2, 2006-01 ,pp. : 87-97

Adis International

Access to resources Recommend Favorite

&ggr;-Secretase as a Therapeutic Target for the Treatment of Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 11, Iss. 26, 2005-10 ,pp. : 3363-3382

Bentham Science Publishers

Access to resources Recommend Favorite

Novel γ-secretase modulators for the treatment of Alzheimer's disease: a review focusing on patents from 2010 to 2012

By Pettersson Martin   Stepan Antonia F   Kauffman Gregory W   Johnson Douglas S  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 10, 2013-10 ,pp. : 1349-1366

Informa Healthcare

Access to resources Recommend Favorite